<DOC>
	<DOCNO>NCT00758316</DOCNO>
	<brief_summary>Background : Malignant pleural effusion form significant proportion respiratory oncology work-load . The efficacy thoracoscopic talc poudrage current standard care limited lung entrapment prevents lung re-expansion . Thoracoscopy patient also significant hospital length stay chest tube drainage must continue pleural space dry effect successful pleurodesis . Alternative management strategy tunnel pleural catheter ( bedside ultrasound-guided ) enable outpatient management pleural effusion limited pleurodesis rate offer chance get pleural biopsy . A prospective randomized control trial two arm i.e . thoracoscopic poudrage alone ( standard care ) versus combine thoracoscopic poudrage tunnel pleural catheter . The tunnelled catheter insert time thoracoscopy endoscopy centre ultrasound guidance . The trial aim complete within 3 year . Primary end-points pleurodesis success . The secondary end-points hospital length-of-stay , complication rate , analgesia requirement , pain score quality-of-life score . Based power calculation , aim recruit 120 patient arm .</brief_summary>
	<brief_title>A Prospective , Randomized Controlled Trial Rapid Pleurodesis Protocol Management Pleural Effusions</brief_title>
	<detailed_description>Malignant effusion 2nd common cause exudative effusion 75 % due lung , breast lymphoma primary . It estimate effusion take 20 % pulmonologists ' work . About 15 % lung cancer effusion presentation 50 % develop effusion course illness . The current standard care symptomatic malignant effusion perform medical thoracoscopy talc poudrage pleurodesis prevent recurrence . Reported pleurodesis success technique 78 % . However , success rate limit presence lung entrapment prevents lung re-expansion effective pleurodesis . Lung entrapment occur visceral pleural tumour peel encase lung endobronchial tumour cause lung/lobar collapse . Thoracoscopic pleurodesis also result significant hospital length stay chest tube must stay situ pleural space dry . There also establish data use outpatient tunnel pleural catheter malignant effusion . Besides provide effective drainage case entrap lung , catheter also result spontaneous pleurodesis 42 70 % case . The attraction catheter enable early discharge patient already terminal illness extremely poor prognosis ( Prognosis usually 3-8 month depend primary ) However , pleural catheter allow biopsy take pleura pleurodesis rate low slow talc poudrage . This project hop capitalize strengths method ie . talc poudrage via thoracoscopy indwell pleural catheter , increase success pleurodesis decrease hospital stay . Indwelling catheter may improve success data drain effusion associate entrapped lung usually achieve pleurodesis talc poudrage alone . These catheter leave patient long term basis i.e . &gt; 6 month . The attraction PleurxTM tunnel catheter system low risk infection , air leak ( one-way valve ) slippage.4-5 This type study involve combine modality never report literature . There trial register clinicaltrials.gov . Pilot data ( &lt; 20 patient ) previously present American College Chest Physicians Conference 2006 Harvard University promise result . Current data thoracoscopy service SGH ( Jan 2004 June 2007 ) , show pleurodesis success rate 78.2 % . However , complete success achieve 38.1 % .7 This data keep reported literature failures/incomplete success attribute lung entrapment.3 Our data hospital length stay 9.0 ± 4.0 ( range 4 21 ) day . We hypothesize combine thoracoscopic talc poudrage tunnel catheter , pleurodesis success rate could improve 15 % 93 % , complete success &gt; 75 % hospital length stay approximately halved 5 day less . To test hypothesis , want conduct prospective , randomize control trial compare thoracoscopic talc poudrage ( standard care ) combine talc poudrage tunnel pleural catheter . Procedure : Patients meet inclusion/exclusion criterion screen investigator trial coordinator . After informed consent take , patient randomize either study arm . Randomization do computer generate random list . Baseline data quality life score compute . Patients undergo standard medical thoracoscopy endoscopy center include use moderate sedation , prophylactic antibiotic 1 week 20F chest tube insertion end procedure . The standard 4-6 g sterilize talc use talc poudrage . In combined procedure group , PleurxTM tunnel catheter insert ultrasound guidance . As procedure do concurrently thoracoscopy , estimate increase endoscopy time . If either group patient find gross evidence malignancy time thoracoscopy ( ie . empyema tuberculous pleurisy ) , withdrawn study notify appropriately . Patients standard therapy arm emerge procedure chest tube intervention arm chest tube tunnel catheter . In standard therapy arm , chest tube remove air leak drainage drop ≤ 150 ml/day . After chest tube removal , patient fit discharge . In intervention arm , chest tube remove air leak stop . There need wait fluid drainage decrease theoretically , patient go home day 3 4 tunnelled pleural catheter . Patients thoracoscopy arm review 1 week outpatient clinic investigator suture removal 1 month evaluation radiological success . This current standard practice . Quality life assessment also do one month visit trial coordinator . Subsequent follow-ups medical oncology per standard practice include visit 3 month , 6 month 1 year . Concurrent chemotherapy radiotherapy allow per current standard care . Concurrent therapy unlikely impact result non-small cell lung cancer form majority referral poor pleural effusion response treatment . This basis pleurodesis current standard care . Chemosensitive tumour like small cell lung cancer , ovarian cancer lymphomas seldom refer symptom management pleural effusion unless refractory chemotherapy . Again , patient affect concurrent 2nd/3rd line therapy . The small group patient may affect simultaneous oncological management first time diagnosis chemosensitive tumour like small cell lung cancer sensitive adenocarcinoma manage Epidermal Growth Factor Tyrosine-kinase ( EGRF ) inhibitor . These patient comprise &lt; 5 % referral analyze separately subsets determine impact data . In pilot review SGH thoracoscopy data , case form tiny proportion ( 1-2 case ) prevent meaningful pilot study analysis . The patient intervention combine treatment arm review outpatient clinic either next day within 48 hour . They undergo drainage via tunnelled catheter . If drainage le 150 ml , PleurxTM catheter remove . Otherwise , patient recall next 24-48 hour till drainage achieve . If drainage persist great 5 visit , patient deem entrapped lung need long term pleural catheterization . Subsequent management bill patient part usual care . In rare occurrence block pleural catheter , fibrinolytic flush ( use streptokinase alteplase ) use . This do use establish protocols management block catheter . The primary end point pleurodesis/pleural catheter success . Complete success define literature minimal re-accumulation pleural fluid 30 day . Partial success define partial ( ≤ 50 % ) re-accumulation fluid resolution symptom absence therapeutic intervention 30 day . If condition meet procedure deem failure . Secondary endpoint 1 . Hospital length stay . This determine primarily primary attend physician base patient 's medical condition . Patients consider 'pleurodesis fit discharge ' day chest tube remove . The chest tube remove absence pleural space infection air-leak ( i.e . complication ) effusion drainage drop ≤ 150 ml/day lung re-expansion . 2 . Complication rate infection , bleed , air-leaks/pneumothorax , tumor seed track 3 . Pain score 4 . Analgesia/sedation requirement 5 . Talc dose require 6 . Quality life analysis use St George 's respiratory questionnaire ( pre post ) , Borg 's scale , ECOG Karnofsky score . 7 . Re-admission repeat procedure rate complication related pleurodesis re-accumulation fluid . We aim track patient 1 year .</detailed_description>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients age ≥ 18 suspect know symptomatic malignant pleural effusion ( i.e . age &gt; 60 smoke history &gt; 20 pack year moderate effusion &gt; 1/3 hemithorax ) 2 . Ability willingness sign inform consent . See Annex 1 patient information sheet informed consent form . 3 . Absence contraindication thoracoscopy tunnelled pleural catheter 4 . Willingness comply followup i.e . outpatient followup 1 week 1 month standard intervention ; additional every day drainage intervention group ( 5 time ) . Exclusion criterion : 1 . Uncorrected coagulopathy platelet count ≤ 60 INR ≥ 1.5 . 2 . Uncontrolled coughing risk lung puncture air leak 3 . Severe hypoxemia PaO2/FiO2 ratio ≤ 200 hypercapnia PaCO2 ≥ 60 mmHg . 4 . Unstable cardiovascular status ie . hemodynamic instability require inotropes/vasopressors , recent myocardial infarction &lt; 5 day uncontrolled arrythmias 5 . Uncontrolled psychiatric disorder absence significant caregiver contraindicate send patient home tunnel catheter 6 . Previous thoracic surgery/intervention affect hemothorax may obliterate pleural space 7 . Local skin infection prevent long term catheter placement 8 . Morbid obesity increase risk associated moderate sedation endoscopy centre 9 . Multiloculated effusion benefit drainage 10 . Suspected pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Malignant</keyword>
	<keyword>Pleural</keyword>
	<keyword>Effusions</keyword>
	<keyword>Thoracoscopy</keyword>
	<keyword>Catheter</keyword>
</DOC>